References
- Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382:727–33.
- World Health Organization. COVID-19 deaths dashboard. Accessed November 2, 2024.
https://data.who.int/dashboards/covid19/deaths . - Ahmad FB, Cisewski JA, Anderson RN. Leading Causes of Death in the US, 2019–2023. JAMA 2024;332:957–8.
- Global report investigating novel coronavirus haplotypes. Pango lineages. Published 2021. Accessed December 20, 2021.
https://cov-lineages.org/index.html - Malli F, Lampropoulos IC, Perlepe G, Papagiannis D, Gourgoulianis KI. Analysis of SARS-CoV-2 Cases, COVID-19 Outcomes and Vaccinations, during the Different SARS-CoV-2 Variants in Greece. Vaccines (Basel) 2023;11:126.
- Government of Greece. COVID-19 information portal. Accessed December 17, 2024.
https://covid19.gov.gr - Horby P, Lim WS, Emberson JR, et al. Dexamethasone in hospitalized patients with COVID-19. N Engl J Med 2021;384:693–704.
- Bhimraj A, Morgan RL, Shumaker AH, et al. Infectious Diseases Society of America guidelines on the treatment and management of patients with COVID-19. Clin Infect Dis 2024;78:e250–e349.
- Demoule A, Vieillard Baron A, Darmon M, et al. High-flow nasal cannula in critically III patients with severe COVID-19. Am J Respir Crit Care Med 2020;202:1039–42.
- Mathews KS, Soh H, Shaefi S, et al. Prone Positioning and Survival in Mechanically Ventilated Patients with Coronavirus Disease 2019-Related Respiratory Failure. Crit Care Med.2021;49:1026–37.
- Kannan S, Shaik Syed Ali P, Sheeza A. Evolving biothreat of variant SARS-CoV-2 - molecular properties, virulence and epidemiology. Eur Rev Med Pharmacol Sci 2021;25:4405–12.
- Haas EJ, McLaughlin JM, Khan F, et al. Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study. Lancet Infect Dis 2022;22:357–66.
- Doidge JC, Gould DW, Ferrando-Vivas P, et al. Trends in Intensive Care for Patients with COVID-19 in England, Wales, and Northern Ireland. Am J Respir Crit Care Med 2021;203:565–74.
- Auld SC, Caridi-Scheible M, Robichaux C, Coopersmith CM, Murphy DJ; Emory COVID-19 Quality and Clinical Research Collaborative. Declines in Mortality Over Time for Critically Ill Adults With Coronavirus Disease 2019. Crit Care Med 2020;48:e1382–4.
- Carbonell R, Urgelés S, Rodríguez A, et al. Mortality comparison between the first and second/third waves among 3,795 critical COVID-19 patients with pneumonia admitted to the ICU: A multicentre retrospective cohort study. Lancet Reg Health Eur 2021;11:100243.
- Karagiannidis C, Windisch W, McAuley DF, Welte T, Busse R. Major differences in ICU admissions during the first and second COVID-19 wave in Germany. Lancet Respir Med 2021; 9:e47–e48.
- Demoule A, Fartoukh M, Louis G, et al. (2022) ICU strain and outcome in COVID-19 patients-A multicenter retrospective observational study. PLoS One 2022;17:e0271358.
- Routsi C, Kokkoris S, Siempos I, et al. Fewer intubations but higher mortality among intubated coronavirus disease 2019 patients during the second than the first wave. Crit Care Explor 2021;3:e531.
- Contou D, Fraissé M, Pajot O, Tirolien JA, Mentec H, Plantefève G. Comparison between first and second wave among critically ill COVID-19 patients admitted to a French ICU: no prognostic improvement during the second wave? Crit Care 2021;25:3.
- Haase N, Plovsing R, Christensen S, et al. Changes over time in characteristics, resource use and outcomes among ICU patients with COVID-19-A nationwide, observational study in Denmark. Acta Anaesthesiol Scand 2022;66:987–95.
- Naouri D, Vuagnat A, Beduneau G, et al. Trends in clinical characteristics and outcomes of all critically ill COVID-19 adult patients hospitalized in France between March 2020 and June 2021: a national database study. Ann Intensive Care 2023;13:2.
- Begum H, Neto AS, Alliegro P, et al. People in intensive care with COVID-19: demographic and clinical features during the first, second, and third pandemic waves in Australia. Med J Aust 2022;217:352–60.
- Termorshuizen F, Dongelmans DA, Brinkman S, et al. Characteristics and outcome of COVID-19 patients admitted to the ICU: a nationwide cohort study on the comparison between the consecutive stages of the COVID-19 pandemic in the Netherlands, an update. Ann Intensive Care 2024;14:11.
- Carrillo-Alcaraz A, Guia M, Lopez-Gomez L, et al. Analysis of combined non-invasive respiratory support in the first six waves of the COVID-19 pandemic. Outcome according to the first respiratory support. Trends Anaesth Crit Care 2023:48:101208.
- Guidet B, Jung C, Flaatten H, et al. Increased 30-day mortality in very old ICU patients with COVID-19 compared to patients with respiratory failure without COVID-19. Intensive Care Med 2022;48:435–47.
- Kokkoris S, Gkoufa A, Maneta E, et al. Older adults with severe coronavirus disease 2019 admitted to intensive care unit; prevalence, characteristics and risk factors for mortality. Minerva Anestesiol 2022; 88:803–14.
- Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818–9.
- Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med1996;22:707–10.
- Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373–83.
- Cecconi M, De Backer D, Antonelli M, et al. Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med 2014;40:1795–815.
- National Institutes of Health. IDSA COVID-19 Treatment Guideline updates: Guidelines development-Concomitant medications. Accessed February 24, 2024.
https://www.covid19treatmentguidelines.nih.gov/concomitant-medications - Grasselli G, Calfee CS, Camporota L, et al. ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies. Intensive Care Med 2023;49:727–59.
- Navaratnam AV, Gray WK, Day J, Wendon J, Briggs TWR. Patient factors and temporal trends associated with COVID-19 in-hospital mortality in England: an observational study using administrative data. Lancet Respir Med 2021;9:397–06.
- Xourgia E, Katsaros DE, Xixi NA, et al. Mortality of intubated patients with COVID-19 during first and subsequent waves: a meta-analysis involving 363,660 patients from 43 countries. Expert Rev Respir Med 2022;16:1101–8.
- Caldonazo T, Treml RE, Vianna FSL, et al. Outcomes comparison between the first and the subsequent SARS-CoV-2 waves-a systematic review and meta-analysis. Multidiscip Respir Med 2023;18:933.
- Anesi GL, Jablonski J, Harhay MO, et al. Characteristics, Outcomes, and Trends of Patients With COVID-19-Related Critical Illness at a Learning Health System in the United States. Ann Intern Med 2021;174:613–21.
- Venkatram S, Dileep A, Fortuzi K, Allena N, Diaz-Fuentes G. Comparison of patients admitted to an inner-city intensive care unit across 3 COVID-19 waves. Medicine (Baltimore) 2023;102:e33069.
- Auld SC, Harrington KRV, Adelman MW, et al. Trends in ICU mortality from Coronavirus Disease 2019: A Tale of Three Surges. Crit Care Med 2022;50:245–55.
- Ganaza-Domingues KLT, Ramos-Milaré ÁCFH, Lera-Nonose DSSL, et al. Effect of Comorbidities on the Mortality of Patients With COVID-19: A Systematic Review of Reviews and Meta-Analyses. Rev Med Virol 2025;35:e70024.